Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simulation Training | 3 | 2022 | 159 | 1.320 |
Why?
|
| Resuscitation | 2 | 2021 | 265 | 1.250 |
Why?
|
| Delivery, Obstetric | 3 | 2023 | 250 | 1.180 |
Why?
|
| Interdisciplinary Communication | 2 | 2018 | 274 | 1.050 |
Why?
|
| Receptors, IgG | 4 | 2019 | 116 | 1.010 |
Why?
|
| Neonatology | 3 | 2019 | 46 | 0.930 |
Why?
|
| Apnea | 1 | 2021 | 36 | 0.780 |
Why?
|
| Cyanosis | 1 | 2021 | 43 | 0.780 |
Why?
|
| Patient Care Team | 4 | 2021 | 826 | 0.750 |
Why?
|
| Pregnancy, High-Risk | 2 | 2018 | 51 | 0.740 |
Why?
|
| Obstetric Labor Complications | 2 | 2018 | 95 | 0.720 |
Why?
|
| Workload | 1 | 2021 | 198 | 0.700 |
Why?
|
| Computers, Handheld | 1 | 2020 | 61 | 0.700 |
Why?
|
| Fetal Viability | 1 | 2019 | 30 | 0.650 |
Why?
|
| Neonatologists | 1 | 2019 | 18 | 0.650 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2018 | 286 | 0.650 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 267 | 0.570 |
Why?
|
| Patient Handoff | 1 | 2017 | 41 | 0.560 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2014 | 278 | 0.540 |
Why?
|
| Counseling | 1 | 2019 | 384 | 0.530 |
Why?
|
| Prenatal Care | 1 | 2019 | 346 | 0.530 |
Why?
|
| C-Reactive Protein | 3 | 2015 | 562 | 0.490 |
Why?
|
| Infant, Newborn | 10 | 2021 | 8597 | 0.480 |
Why?
|
| Carotid Artery Injuries | 1 | 2011 | 48 | 0.390 |
Why?
|
| Endothelial Cells | 3 | 2019 | 1045 | 0.360 |
Why?
|
| Pregnancy | 11 | 2023 | 8045 | 0.340 |
Why?
|
| Hypertension | 2 | 2019 | 1620 | 0.330 |
Why?
|
| src-Family Kinases | 1 | 2011 | 487 | 0.320 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 2 | 2018 | 13 | 0.310 |
Why?
|
| Obesity | 2 | 2019 | 2940 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 687 | 0.230 |
Why?
|
| Patient Simulation | 1 | 2023 | 45 | 0.210 |
Why?
|
| Twins, Conjoined | 1 | 2023 | 30 | 0.210 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 61 | 0.210 |
Why?
|
| Ventricular Function | 1 | 2003 | 100 | 0.210 |
Why?
|
| Angiotensin II | 1 | 2003 | 206 | 0.200 |
Why?
|
| Apgar Score | 1 | 2021 | 55 | 0.190 |
Why?
|
| Heart Rate, Fetal | 1 | 2021 | 59 | 0.190 |
Why?
|
| Umbilical Arteries | 1 | 2021 | 93 | 0.190 |
Why?
|
| Labor, Obstetric | 1 | 2021 | 95 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 649 | 0.180 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2019 | 35 | 0.170 |
Why?
|
| Heart | 2 | 2003 | 1211 | 0.170 |
Why?
|
| Hexosamines | 1 | 2019 | 28 | 0.170 |
Why?
|
| Gestational Age | 2 | 2019 | 1143 | 0.160 |
Why?
|
| Lymphatic Abnormalities | 1 | 2019 | 30 | 0.160 |
Why?
|
| Teratoma | 1 | 2021 | 255 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2014 | 5784 | 0.160 |
Why?
|
| Perinatal Care | 1 | 2019 | 68 | 0.160 |
Why?
|
| Fetal Diseases | 2 | 2019 | 449 | 0.150 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 373 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 705 | 0.150 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 140 | 0.150 |
Why?
|
| Placenta Diseases | 1 | 2018 | 60 | 0.150 |
Why?
|
| Myocardium | 1 | 2003 | 1248 | 0.140 |
Why?
|
| Video Recording | 1 | 2019 | 276 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 1725 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 246 | 0.140 |
Why?
|
| Neck | 1 | 2019 | 386 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2020 | 644 | 0.130 |
Why?
|
| Health Personnel | 1 | 2021 | 643 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 4370 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 1152 | 0.120 |
Why?
|
| Serum Amyloid P-Component | 1 | 2014 | 31 | 0.120 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 607 | 0.120 |
Why?
|
| Cesarean Section | 1 | 2018 | 386 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 7218 | 0.120 |
Why?
|
| Humans | 15 | 2023 | 271076 | 0.120 |
Why?
|
| Hysterectomy | 1 | 2018 | 644 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 690 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2014 | 5838 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 741 | 0.110 |
Why?
|
| Sheep | 2 | 2003 | 277 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2014 | 350 | 0.110 |
Why?
|
| Time Factors | 2 | 2020 | 13130 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2020 | 1326 | 0.100 |
Why?
|
| Female | 12 | 2023 | 148608 | 0.100 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2011 | 12 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 916 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 134 | 0.100 |
Why?
|
| Decision Making | 1 | 2019 | 1244 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2014 | 664 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 265 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2426 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 1079 | 0.090 |
Why?
|
| Rabbits | 1 | 2011 | 1110 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 7464 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 847 | 0.090 |
Why?
|
| Fetus | 2 | 2022 | 674 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2019 | 2736 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2014 | 1600 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2011 | 1837 | 0.080 |
Why?
|
| Animals | 7 | 2019 | 62871 | 0.070 |
Why?
|
| Transfection | 1 | 2011 | 3172 | 0.070 |
Why?
|
| Male | 6 | 2021 | 128555 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 5898 | 0.060 |
Why?
|
| Inflammation | 1 | 2014 | 2526 | 0.060 |
Why?
|
| Hematocrit | 1 | 2003 | 157 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2011 | 4986 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 139 | 0.050 |
Why?
|
| Pterins | 1 | 2002 | 10 | 0.050 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2002 | 16 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2003 | 159 | 0.050 |
Why?
|
| Mice | 3 | 2014 | 35996 | 0.050 |
Why?
|
| Adult | 5 | 2021 | 81614 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2003 | 180 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 634 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2003 | 339 | 0.050 |
Why?
|
| Pregnancy, Twin | 1 | 2023 | 170 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 175 | 0.050 |
Why?
|
| Cardiotocography | 1 | 2021 | 19 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2282 | 0.050 |
Why?
|
| Blood Gas Analysis | 1 | 2021 | 106 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2003 | 579 | 0.050 |
Why?
|
| Trachea | 1 | 2022 | 290 | 0.050 |
Why?
|
| Acidosis | 1 | 2021 | 117 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 580 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 254 | 0.040 |
Why?
|
| Infant Care | 1 | 2019 | 46 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 887 | 0.040 |
Why?
|
| Cell Division | 1 | 2003 | 2718 | 0.040 |
Why?
|
| Oxygen | 1 | 2003 | 800 | 0.040 |
Why?
|
| Fetoscopy | 1 | 2022 | 404 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7295 | 0.040 |
Why?
|
| Parturition | 1 | 2019 | 64 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2003 | 846 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2019 | 175 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 675 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 337 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 12207 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2019 | 317 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2021 | 39710 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 653 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 910 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 569 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 1576 | 0.030 |
Why?
|
| Infant | 2 | 2019 | 13920 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 443 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 2508 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 5183 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 1061 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 2465 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 2083 | 0.020 |
Why?
|
| Logistic Models | 1 | 2018 | 3437 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 32595 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 9434 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 4327 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 5107 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 4124 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 7950 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 16981 | 0.010 |
Why?
|
| Sweat Glands | 1 | 2002 | 3 | 0.010 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2002 | 7 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2002 | 15 | 0.010 |
Why?
|
| Pteridines | 1 | 2002 | 35 | 0.010 |
Why?
|
| Catecholamines | 1 | 2002 | 99 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 88 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 2002 | 51 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2002 | 110 | 0.010 |
Why?
|
| Foot | 1 | 2002 | 108 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2002 | 285 | 0.010 |
Why?
|
| Dopamine | 1 | 2002 | 342 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 17835 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 22062 | 0.010 |
Why?
|
| Child | 1 | 2021 | 30421 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 1290 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 3649 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 33833 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 6465 | 0.010 |
Why?
|